Clinical Trial Update: Treatment With Apremilast in Patients With Psoriatic Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 trial of Apremilast for psoriatic arthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• OTEZLA (apremilast)

Snippet

Sponsor: University of South Florida | Conditions: Psoriatic Arthritis | Phase 4 | Status: WITHDRAWN